Company research / RAJAF
TFA Therapeutics, Inc. (RAJAF)
- Sector Manufacturing
- Fiscal year ends Dec 31
For the year ended 2025-12-31, TFA Therapeutics, Inc. reported revenue of $1.25M. Revenue fell 0.6% from the prior annual period.
Key ratios (year ended 2025-12-31)
61.1%
Gross margin
-11.3%
Operating margin
-12.4%
Net margin
-0.6%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.